K
Kristin R. Swanson
Researcher at Mayo Clinic
Publications - 191
Citations - 9116
Kristin R. Swanson is an academic researcher from Mayo Clinic. The author has contributed to research in topics: Glioma & Magnetic resonance imaging. The author has an hindex of 47, co-authored 183 publications receiving 7761 citations. Previous affiliations of Kristin R. Swanson include University of Washington & Arizona's Public Universities.
Papers
More filters
Posted ContentDOI
Image-based metric of invasiveness predicts response to adjuvant temozolomide for primary glioblastoma
Susan Christine Massey,Haylye White,Paula Whitmire,Tatum E. Doyle,Sandra K. Johnston,Kyle W. Singleton,Pamela R. Jackson,Andrea Hawkins-Daarud,Bernard R. Bendok,Alyx B. Porter,Sujay A. Vora,Jann N. Sarkaria,Maciej M. Mrugala,Kristin R. Swanson +13 more
TL;DR: The finding that less diffusely invasive tumors are associated with greater volumetric response to TMZ suggests that patients with these tumors may benefit from additional cycles of adjuvant TMZ, even for those without MGMT methylation.
Book ChapterDOI
Sex Differences in Predicting Fluid Intelligence of Adolescent Brain from T1-Weighted MRIs
Sara Ranjbar,Kyle W. Singleton,Lee Curtin,Susan Christine Massey,Andrea Hawkins-Daarud,Pamela R. Jackson,Kristin R. Swanson +6 more
TL;DR: In this article, the authors used atlas-aligned volumetric T1-weighted (T1 W) MRIs to predict fluid intelligence (Gf) in children aged 9-10.
Posted ContentDOI
Glioblastoma recurrence and the role of MGMT promoter methylation
Katie Storey,Kevin Leder,Andrea Hawkins-Daarud,Kristin R. Swanson,Atique Ahmed,Russell C. Rockne,Jasmine Foo +6 more
TL;DR: A mathematical model is developed, parameterized using clinical and experimental data, to investigate the role of MGMT methylation in TMZ resistance during the standard treatment regimen for GBM, finding that the observed downward shift in MGMT promoter methylation status between detection and recurrence cannot be explained solely by evolutionary selection.
Journal ArticleDOI
Rt-08proton therapy (pt) large-volume re-irradiation for recurrent glioma: overall survival (os) and toxicity outcomes
Brijal Desai,Russell C. Rockne,Alfred Rademaker,Jeffrey Raizer,Nina Paleologos,Ryan Merrell,Sean Grimm,Syed Azeem,William F. Hartsell,Patrick Sweeney,Kristin R. Swanson,Vinai Gondi +11 more
TL;DR: Large-volume PT re-irradiation for recurrent glioma is safe and associated with promising OS outcomes, particularly in the setting of bevacizumab-refractory tumors.
Posted ContentDOI
Assessment of Prognostic Value of Cystic Features in Glioblastoma Relative to Sex and Treatment with Standard-of-Care
Lee Curtin,Paula Whitmire,Cassandra R. Rickertsen,Gina L. Mazza,Peter Canoll,Sandra K. Johnston,Maciej M. Mrugala,Kristin R. Swanson,Leland S. Hu +8 more
TL;DR: In this article, the authors performed an exploratory analysis on the potential link between cysts and survival using pre-treatment MRIs, and found that patients with cysts had significantly longer overall survival and were significantly younger at presentation.